Karyopherinβ1 regulates proliferation of human glioma cells via Wnt/β-catenin pathway

Biochemical and Biophysical Research Communications

Volumn 478, Issue 3, 2016, Pages 1189-1197

  Lu, Ting ^a   Bao, Zhen ^b   Wang, Yunfeng ^a   Yang, Lixiang ^a   Lu, Bing ^a   Yan, Ke ^a   Wang, Shaozhen ^a   Wei, He ^a   Zhang, Zhe ^c   Cui, Gang ^a  

^a THE FIRST AFFILIATED HOSPITAL OF SOOCHOW UNIVERSITY   (China)

^b The First Affiliated Hospital of Soochow University   (China)

^c NANTONG UNIVERSITY   (China)

Author keywords

Human glioma; KPNB1; Proliferation; Wnt Catenin

Indexed keywords

BETA CATENIN; KARYOPHERIN BETA; KARYOPHERIN BETA1; UNCLASSIFIED DRUG; WNT PROTEIN; KI 67 ANTIGEN; KPNB1 PROTEIN, HUMAN; PROTEIN BINDING;

ADULT; ARTICLE; CANCER TISSUE; CELL CYCLE G1 PHASE; CELL PROLIFERATION; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; GENE SILENCING; GLIOMA; GLIOMA CELL LINE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOPRECIPITATION; IN VITRO STUDY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; REGULATORY MECHANISM; UPREGULATION; BRAIN TUMOR; CANCER GRADING; CELL CYCLE; CELL NUCLEUS; DOWN REGULATION; GENETICS; METABOLISM; MIDDLE AGED; PATHOLOGY; PROGNOSIS; PROTEIN TRANSPORT; SURVIVAL ANALYSIS; TUMOR CELL LINE; WNT SIGNALING PATHWAY; WORLD HEALTH ORGANIZATION;

ADULT; BETA CATENIN; BETA KARYOPHERINS; BRAIN NEOPLASMS; CELL CYCLE; CELL LINE, TUMOR; CELL NUCLEUS; CELL PROLIFERATION; DOWN-REGULATION; FEMALE; GLIOMA; HUMANS; KI-67 ANTIGEN; MALE; MIDDLE AGED; NEOPLASM GRADING; PROGNOSIS; PROTEIN BINDING; PROTEIN TRANSPORT; SURVIVAL ANALYSIS; WNT SIGNALING PATHWAY; WORLD HEALTH ORGANIZATION;

EID: 84992735258     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2016.08.093     Document Type: Article

References (34)

1. [1] Deorah, S., Lynch, C.F., Sibenaller, Z.A., Ryken, T.C., Trends in brain cancer incidence and survival in the United States: surveillance, epidemiology, and end results program, 1973 to 2001. Neurosurg. focus, 20, 2006, E1.
2. [2] Reardon, D.A., Herndon, J.E. 2nd, Peters, K.B., et al. Bevacizumab continuation beyond initial bevacizumab progression among recurrent glioblastoma patients. Br. J. cancer 107 (2012), 1481–1487.
3. [3] Maher, E.A., Furnari, F.B., Bachoo, R.M., et al. Malignant glioma: genetics and biology of a grave matter. Genes & Dev. 15 (2001), 1311–1333.
4. [4] Zhuang, W., Qin, Z., Liang, Z., The role of autophagy in sensitizing malignant glioma cells to radiation therapy. Acta biochimica biophysica Sinica 41 (2009), 341–351.
5. [5] Wen, P.Y., Kesari, S., Malignant gliomas in adults. N. Engl. J. Med. 359 (2008), 492–507.
6. [6] Polakis, P., Wnt signaling and cancer. Genes & Dev. 14 (2000), 1837–1851.
7. [7] Cho, I.R., Koh, S.S., Min, H.J., et al. Pancreatic adenocarcinoma up-regulated factor (PAUF) enhances the expression of beta-catenin, leading to a rapid proliferation of pancreatic cells. Exp. Mol. Med. 43 (2011), 82–90.
8. [8] He, T.C., Sparks, A.B., Rago, C., et al. Identification of c-MYC as a target of the APC pathway. Science 281 (1998), 1509–1512.
9. [9] He, T.C., Chan, T.A., Vogelstein, B., Kinzler, K.W., PPARdelta is an APC-regulated target of nonsteroidal anti-inflammatory drugs. Cell 99 (1999), 335–345.
10. [10] Tetsu, O., McCormick, F., Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature 398 (1999), 422–426.
11. [11] van Noort, M., Meeldijk, J., van der Zee, R., Destree, O., Clevers, H., Wnt signaling controls the phosphorylation status of beta-catenin. J. Biol. Chem. 277 (2002), 17901–17905.
12. [12] Nakielny, S., Dreyfuss, G., Transport of proteins and RNAs in and out of the nucleus. Cell 99 (1999), 677–690.
13. [13] Mosammaparast, N., Pemberton, L.F., Karyopherins: from nuclear-transport mediators to nuclear-function regulators. Trends cell Biol. 14 (2004), 547–556.
14. [14] Nishimura, A.L., Zupunski, V., Troakes, C., et al. Nuclear import impairment causes cytoplasmic trans-activation response DNA-binding protein accumulation and is associated with frontotemporal lobar degeneration. Brain J. Neurol. 133 (2010), 1763–1771.
15. [15] Lange, A., Mills, R.E., Lange, C.J., Stewart, M., Devine, S.E., Corbett, A.H., Classical nuclear localization signals: definition, function, and interaction with importin alpha. J. Biol. Chem. 282 (2007), 5101–5105.
16. [16] Sorokin, A.V., Kim, E.R., Ovchinnikov, L.P., Nucleocytoplasmic transport of proteins. Biochem. Biokhimiia 72 (2007), 1439–1457.
17. [17] Terry, L.J., Shows, E.B., Wente, S.R., Crossing the nuclear envelope: hierarchical regulation of nucleocytoplasmic transport. Science 318 (2007), 1412–1416.
18. [18] Kutay, U., Bischoff, F.R., Kostka, S., Kraft, R., Gorlich, D., Export of importin alpha from the nucleus is mediated by a specific nuclear transport factor. Cell 90 (1997), 1061–1071.
19. [19] Martens-de Kemp, S.R., Nagel, R., Stigter-van Walsum, M., et al. Functional genetic screens identify genes essential for tumor cell survival in head and neck and lung cancer. Clin. Cancer Res. Official J. Am. Assoc. Cancer Res. 19 (2013), 1994–2003.
20. [20] Huang, X., Liu, F., Zhu, C., et al. Suppression of KIF3B expression inhibits human hepatocellular carcinoma proliferation. Dig. Dis. Sci. 59 (2014), 795–806.
21. [21] Ding, Z., Liu, X., Liu, Y., et al. Expression of far upstream element (FUSE) binding protein 1 in human glioma is correlated with c-Myc and cell proliferation. Mol. Carcinog. 54:5 (2013), 405–415, 10.1002/mc.22114.
22. [22] Lin, S.Y., Makino, K., Xia, W., et al. Nuclear localization of EGF receptor and its potential new role as a transcription factor. Nat. cell Biol. 3 (2001), 802–808.
23. [23] Giri, D.K., Ali-Seyed, M., Li, L.Y., et al. Endosomal transport of ErbB-2: mechanism for nuclear entry of the cell surface receptor. Mol. Cell. Biol. 25 (2005), 11005–11018.
24. [24] Ferguson, S.D., Malignant gliomas: diagnosis and treatment. Disease-a-month DM 57 (2011), 558–569.
25. [25] Stupp, R., Hegi, M.E., van den Bent, M.J., et al. Changing paradigms–an update on the multidisciplinary management of malignant glioma. Oncologist 11 (2006), 165–180.
26. [26] Qi, S., Song, Y., Peng, Y., et al. ZEB2 mediates multiple pathways regulating cell proliferation, migration, invasion, and apoptosis in glioma. PLoS one, 7, 2012, e38842.
27. [27] Yang, L., Hu, B., Zhang, Y., et al. Suppression of the nuclear transporter-KPNbeta1 expression inhibits tumor proliferation in hepatocellular carcinoma. Med. Oncol., 32, 2015, 128.
28. [28] Radner, H., Blumcke, I., Reifenberger, G., Wiestler, O.D., [The new WHO classification of tumors of the nervous system 2000. Pathology and genetics]. Der Pathol. 23 (2002), 260–283.
29. [29] Larriba, M.J., Gonzalez-Sancho, J.M., Barbachano, A., Niell, N., Ferrer-Mayorga, G., Munoz, A., Vitamin D is a multilevel repressor of Wnt/b-catenin signaling in Cancer cells. Cancers 5 (2013), 1242–1260.
30. [30] Willert, K., Nusse, R., Wnt proteins. Cold Spring Harb. Perspect. Biol., 4, 2012, a007864.
31. [31] Niehrs, C., The complex world of WNT receptor signalling. Nature reviews. Mol. cell Biol. 13 (2012), 767–779.
32. [32] Hikasa, H., Ezan, J., Itoh, K., Li, X., Klymkowsky, M.W., Sokol, S.Y., Regulation of TCF3 by Wnt-dependent phosphorylation during vertebrate axis specification. Dev. cell 19 (2010), 521–532.
33. [33] Sugioka, K., Mizumoto, K., Sawa, H., Wnt regulates spindle asymmetry to generate asymmetric nuclear beta-catenin in C. elegans. Cell 146 (2011), 942–954.
34. [34] Clevers, H., Nusse, R., Wnt/beta-catenin signaling and disease. Cell 149 (2012), 1192–1205.